These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8531083)

  • 1. Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist.
    Woodward RM; Huettner JE; Tran M; Guastella J; Keana JF; Weber E
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1209-18. PubMed ID: 8531083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
    Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
    Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
    Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
    Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
    Lutfy K; Shen KZ; Woodward RM; Weber E
    Brain Res; 1996 Aug; 731(1-2):171-81. PubMed ID: 8883867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor.
    Lingenhöhl K; Pozza MF
    Neuropharmacology; 1998 Jun; 37(6):729-37. PubMed ID: 9707286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
    Lutfy K; Doan P; Nugyen M; Weber E
    Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of NMDA receptor glycine recognition site antagonism: dependence on glycine concentration.
    Pearlstein RD; Beirne JP; Massey GW; Warner DS
    J Neurochem; 1998 May; 70(5):2012-9. PubMed ID: 9572287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.
    Keana JF; Kher SM; Cai SX; Dinsmore CM; Glenn AG; Guastella J; Huang JC; Ilyin V; Lü Y; Mouser PL
    J Med Chem; 1995 Oct; 38(22):4367-79. PubMed ID: 7473565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors.
    Wilding TJ; Huettner JE
    Mol Pharmacol; 1996 Mar; 49(3):540-6. PubMed ID: 8643094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
    Nishiyama T
    Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
    Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER; Ilyin VI; Woodward RM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity.
    Matsumoto RR; Brackett RL; Kanthasamy AG
    Eur J Pharmacol; 1997 Nov; 338(3):233-42. PubMed ID: 9424017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
    Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
    J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.